President and owner of Group ATES, consisting of Ates Medical, Go Medical and Benrikal Sevices, with headquarters located in St-Bruno, Quebec. Group ATES specializes in partnering globally with key opinion leaders in research, and developing new technologies, manufacturing, distribution of innovative products at competitive prices to help physicians effectively meet healthcare needs. ATES Medical operates as sales and distribution of medical devices as a member of Group ATES and has distribution globally, including Europe, United States and Canada. Benrikal Medical Services, member of Group ATES, specializes in research and new product development and is manufacturer of the patented Bengal™ Radial Compression Band. Uniquely designed for transradial procedures, the Bengal™ Radial Compression Band offers unprecedented control to achieve radial hemostasis. The simple yet elegant design optimizes targeted compression and maximizes manual control throughout deployment, adjustment, and removal. Transparent polymer provides clear visualization of any bleeding from access site.

Develop strategic business plan to achieve the Revenue & Expense goals for the region.Establish a market leadership position for SJM’s CVA products. Develop and maintain strong relationships with our key customers in the regionWork with the Clinical Programs Manager to develop new clinical opportunities for the Canadian market Total annual sales in 2005 : $1.8M 110% vs Profit plan. 45% of Canada’s total sales Total annual sales in 2006 : $2.1M 114% vs Profit plan. 50% of Canada’s total sales

Contribute to the efforts required to gain or maintain Biovail products on Hospital FormulariesIdentify, develop, and train Specialists that will promote the usage of Biovail products through CHE Speaker activities and other CHE-related events.Develop relationships with cardiologists and Nephrologists of 9 Hospitals on South Shore of Montréal Area and Eastern Township.Establish a new CHE program for GP to reduce waiting list in Psychiatry.Total annual sales target in 2004 on territory: $4M 140% vs Profit plan.

Contribute to the efforts required to gain or maintain MFCL products on Hospital formularies and Quebec Formularies.Contribute to the development relationship with several Specialist’s Association (Quebec Hypertension Society, Canadian Diabetes Association, Quebec Cardiologist Association, Quebec Internist Association Canadian Hypertension Society and others).Develop relationships with Quebec and Canadian Health Departments and Agencies. Together with Government Health Departments, Several specialist Associations and University Hospital Research Centers, establish strategies regarding research subsidies.Total annual sales target in 2003 on territory: $12M Objective in 2001, 2002 vs ‘‘Profit Plan’’ : 130 % Objective in 2003 vs ‘‘Profit Plan’’ : 140%